Monoclonal gammopathy-associated pure red cell aplasia

Neha Korde, Yong Zhang, Kelsey Loeliger, Andrea Poon, Olga Simakova, Adriana Zingone, Rene Costello, Richard Childs, Pierre Noel, Samuel Silver, Mary Kwok, Clifton Mo, Neal Young, Ola Landgren, Elaine Sloand, Irina Maric

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Pure red cell aplasia (PRCA) is a rare disorder characterized by inhibition of erythroid precursors in the bone marrow and normochromic, normocytic anaemia with reticulocytopenia. Among 51 PRCA patients, we identified 12 (24%) patients having monoclonal gammopathy, monoclonal gammopathy of undetermined significance or smouldering multiple myeloma, with presence of monoclonal protein or abnormal serum free light chains and atypical bone marrow features of clonal plasmacytosis, hypercellularity and fibrosis. Thus far, three patients treated with anti-myeloma based therapeutics have responded with reticulocyte recovery and clinical transfusion independence, suggesting plasma cells play a key role in the pathogenesis of this specific monoclonal gammopathy-associated PRCA.

Original languageEnglish (US)
Pages (from-to)876-883
Number of pages8
JournalBritish Journal of Haematology
Volume173
Issue number6
DOIs
StatePublished - Jun 1 2016
Externally publishedYes

Fingerprint

Pure Red-Cell Aplasia
Paraproteinemias
Bone Marrow
Monoclonal Gammopathy of Undetermined Significance
Reticulocytes
Plasma Cells
Multiple Myeloma
Anemia
Fibrosis
Light
Serum
Proteins
Therapeutics

Keywords

  • anaemia
  • monoclonal gammopathy of undetermined significance
  • myeloma
  • plasmacytosis
  • pure red cell aplasia

ASJC Scopus subject areas

  • Hematology

Cite this

Korde, N., Zhang, Y., Loeliger, K., Poon, A., Simakova, O., Zingone, A., ... Maric, I. (2016). Monoclonal gammopathy-associated pure red cell aplasia. British Journal of Haematology, 173(6), 876-883. https://doi.org/10.1111/bjh.14012

Monoclonal gammopathy-associated pure red cell aplasia. / Korde, Neha; Zhang, Yong; Loeliger, Kelsey; Poon, Andrea; Simakova, Olga; Zingone, Adriana; Costello, Rene; Childs, Richard; Noel, Pierre; Silver, Samuel; Kwok, Mary; Mo, Clifton; Young, Neal; Landgren, Ola; Sloand, Elaine; Maric, Irina.

In: British Journal of Haematology, Vol. 173, No. 6, 01.06.2016, p. 876-883.

Research output: Contribution to journalArticle

Korde, N, Zhang, Y, Loeliger, K, Poon, A, Simakova, O, Zingone, A, Costello, R, Childs, R, Noel, P, Silver, S, Kwok, M, Mo, C, Young, N, Landgren, O, Sloand, E & Maric, I 2016, 'Monoclonal gammopathy-associated pure red cell aplasia', British Journal of Haematology, vol. 173, no. 6, pp. 876-883. https://doi.org/10.1111/bjh.14012
Korde N, Zhang Y, Loeliger K, Poon A, Simakova O, Zingone A et al. Monoclonal gammopathy-associated pure red cell aplasia. British Journal of Haematology. 2016 Jun 1;173(6):876-883. https://doi.org/10.1111/bjh.14012
Korde, Neha ; Zhang, Yong ; Loeliger, Kelsey ; Poon, Andrea ; Simakova, Olga ; Zingone, Adriana ; Costello, Rene ; Childs, Richard ; Noel, Pierre ; Silver, Samuel ; Kwok, Mary ; Mo, Clifton ; Young, Neal ; Landgren, Ola ; Sloand, Elaine ; Maric, Irina. / Monoclonal gammopathy-associated pure red cell aplasia. In: British Journal of Haematology. 2016 ; Vol. 173, No. 6. pp. 876-883.
@article{41c1308467fa4db996f456a27d189151,
title = "Monoclonal gammopathy-associated pure red cell aplasia",
abstract = "Pure red cell aplasia (PRCA) is a rare disorder characterized by inhibition of erythroid precursors in the bone marrow and normochromic, normocytic anaemia with reticulocytopenia. Among 51 PRCA patients, we identified 12 (24{\%}) patients having monoclonal gammopathy, monoclonal gammopathy of undetermined significance or smouldering multiple myeloma, with presence of monoclonal protein or abnormal serum free light chains and atypical bone marrow features of clonal plasmacytosis, hypercellularity and fibrosis. Thus far, three patients treated with anti-myeloma based therapeutics have responded with reticulocyte recovery and clinical transfusion independence, suggesting plasma cells play a key role in the pathogenesis of this specific monoclonal gammopathy-associated PRCA.",
keywords = "anaemia, monoclonal gammopathy of undetermined significance, myeloma, plasmacytosis, pure red cell aplasia",
author = "Neha Korde and Yong Zhang and Kelsey Loeliger and Andrea Poon and Olga Simakova and Adriana Zingone and Rene Costello and Richard Childs and Pierre Noel and Samuel Silver and Mary Kwok and Clifton Mo and Neal Young and Ola Landgren and Elaine Sloand and Irina Maric",
year = "2016",
month = "6",
day = "1",
doi = "10.1111/bjh.14012",
language = "English (US)",
volume = "173",
pages = "876--883",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Monoclonal gammopathy-associated pure red cell aplasia

AU - Korde, Neha

AU - Zhang, Yong

AU - Loeliger, Kelsey

AU - Poon, Andrea

AU - Simakova, Olga

AU - Zingone, Adriana

AU - Costello, Rene

AU - Childs, Richard

AU - Noel, Pierre

AU - Silver, Samuel

AU - Kwok, Mary

AU - Mo, Clifton

AU - Young, Neal

AU - Landgren, Ola

AU - Sloand, Elaine

AU - Maric, Irina

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Pure red cell aplasia (PRCA) is a rare disorder characterized by inhibition of erythroid precursors in the bone marrow and normochromic, normocytic anaemia with reticulocytopenia. Among 51 PRCA patients, we identified 12 (24%) patients having monoclonal gammopathy, monoclonal gammopathy of undetermined significance or smouldering multiple myeloma, with presence of monoclonal protein or abnormal serum free light chains and atypical bone marrow features of clonal plasmacytosis, hypercellularity and fibrosis. Thus far, three patients treated with anti-myeloma based therapeutics have responded with reticulocyte recovery and clinical transfusion independence, suggesting plasma cells play a key role in the pathogenesis of this specific monoclonal gammopathy-associated PRCA.

AB - Pure red cell aplasia (PRCA) is a rare disorder characterized by inhibition of erythroid precursors in the bone marrow and normochromic, normocytic anaemia with reticulocytopenia. Among 51 PRCA patients, we identified 12 (24%) patients having monoclonal gammopathy, monoclonal gammopathy of undetermined significance or smouldering multiple myeloma, with presence of monoclonal protein or abnormal serum free light chains and atypical bone marrow features of clonal plasmacytosis, hypercellularity and fibrosis. Thus far, three patients treated with anti-myeloma based therapeutics have responded with reticulocyte recovery and clinical transfusion independence, suggesting plasma cells play a key role in the pathogenesis of this specific monoclonal gammopathy-associated PRCA.

KW - anaemia

KW - monoclonal gammopathy of undetermined significance

KW - myeloma

KW - plasmacytosis

KW - pure red cell aplasia

UR - http://www.scopus.com/inward/record.url?scp=84973607394&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973607394&partnerID=8YFLogxK

U2 - 10.1111/bjh.14012

DO - 10.1111/bjh.14012

M3 - Article

C2 - 26999424

AN - SCOPUS:84973607394

VL - 173

SP - 876

EP - 883

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -